Posted:
1/23/2025, 3:15:57 AM
Location(s):
North Carolina, United States ⋅ Durham, North Carolina, United States
Experience Level(s):
Expert or higher ⋅ Senior
Field(s):
IT & Security
Workplace Type:
Hybrid
Company Overview:
Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform that includes a suite of gene editing and delivery technologies and is in the process of building internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.
Position Overview:
The Lead IT Technical Analyst, MES Systems role, reporting to the Director, IT Business Partner – Technical Operations, will have a lead role in implementing and providing ongoing support for Beam’s Manufacturing Execution System implementation and will assist with other IT systems supporting manufacturing, automation, and supply chain in a rapidly growing organization. This role will directly impact Beam's ability to develop our therapies by helping to support and our gene therapy manufacturing facility in Durham, North Carolina.
This role will work with IT team members, functional business experts, and external vendors to ensure successful delivery of Beam’s MES system. The candidate will act as a business analyst, project manager, and technical lead for MES.
Responsibilities:
Qualifications:
Website: https://beamtx.com/
Headquarter Location: Cambridge, Massachusetts, United States
Employee Count: 501-1000
Year Founded: 2017
IPO Status: Public
Last Funding Type: Post-IPO Equity
Industries: Biotechnology ⋅ Genetics ⋅ Medical ⋅ Therapeutics